CTNNB1 and osteoporosis: Consistent with our in vitro experiments, we reported in the present study that DANCR and miR-320a were overexpressed and CTNNB1 was expressed at low levels in our osteoporosis mouse model, leading to the inhibition of the β-catenin signaling pathway.